The University of California, Los Angeles, is studying transcutaneous electrical acupoint stimulation (TEAS) for relieving chronic constipation. They rely on TMS through non-invasive alteration of nerve activity, or neuromodulation. This is an acupuncture-based form of self-care treatment.
Interested persons will undergo a phone screening. If selected, they will complete a bowel logbook at home for 2 weeks. They will report back to the office to complete a survey and have a picture taken of their tongue. Instructions for where to place the TEAS device will be given. It should be used at least 30 minutes for 5 days a week.
- All sexes, ages 18 years or older
- Fewer than three spontaneous bowel movements per week
- Meet one of the following symptoms for at least 12 weeks in the preceding 12 months:
- straining during more than 25% of time
- lumpy or hard stools during more than 25% of time
- feeling of incomplete evacuation during more than 25% of time
- feeling of blockage in large intestine more than 25% of time
- manual movement to assist bowel movements more than 25% of time
- loose stools are rare without the use of laxatives
- able to understand and provide written consent
- If over age 50, have undergone routine colon cancer screening (colonoscopy, sigmoidoscopy, colonography or fecal occult blood testing)
- Must have normal serum chemistry and normal thyroid stimulating hormone (TSH) within the past year
- Must have normal feeling over the areas where the pads will be placed (lumbar region and lower extremities surrounding the knees anteriorly)
- Numbness around the genitals or groin
- bladder or bowel dysfunction or incontinence,
- new sciatica type leg pain or new onset sexual dysfunction within the past year.
- Any changes to constipation related medications in the past 1 month
- Use of rescue medication (polyethylene glycol, bisacodyl, enema, etc) more than once per week
- Pacemaker, implanted cardiac defibrillator or other implanted electrical device
- 10% weight loss in past 6 months
- Passing blood in stools since last medical evaluation
You may participate in this study at the University of California in Los Angeles, California, 90095. If you have any questions feel free to contact Andre Shubov, MD at 310-998-9118 or at firstname.lastname@example.org.
This study is sponsored by the University of California, Los Angeles with Andrew Shubov, MD as the Principal Investigator.
Clinical TrialsView All Clinical Trials
Efficacy and Safety of SYN-010 in IBS-C
Cedars-Sinai Medical Center is holding a clinical trial on the effectiveness of SYN-010 in the treatment of…
Linaclotide Safety and Efficacy in 2 to 5-Year-Olds
Allergen and Ironwood Pharmaceuticals Inc. are holding a clinical trial on the effectiveness of the drug…
Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders
Indiana University is holding a clinical trial that analyzes the numerous factors that may contribute to functional…
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
The University of Michigan is testing the effectiveness of PEG 3350 (Miralax) and low FODMAP diet for people with…
Microbiome Analysis of Constipated Versus Non-Constipated Patients
This study uses HyGieaCare and biological microbiome therapy in an attempt to provide relief for people with…